查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594482

神经血管导管市场：按类型、应用和最终用途分类－2025-2030 年全球预测

Neurovascular Catheters Market by Type (Access Catheters, Balloon Catheters, Embolization Catheters), Application (Arteriovenous Malformations, Brain Aneurysm, Embolic Stroke), End-use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

神经血管导管市场2023年估值为43.7亿美元，预计到2024年将达到49亿美元，复合年增长率为12.01%，预计到2030年将达到96.8亿美元。

神经血管导管对于治疗脑血管疾病至关重要，包括用于诊断和介入神经血管手术（例如栓塞、血栓切除术和血管成形术）的装置。神经血管疾病的盛行率不断上升、微创手术的技术进步以及医疗保健支出的增加正在推动对这些设备的需求，从而需要开发它们来改善患者的治疗效果。主要应用在医院和神经科科诊所，最终用途受到不断增长的易患神经血管疾病的老年人口的极大影响。目前市场的成长得益于导管技术的快速进步，包括灵活性、耐用性和可提高手术有效性和安全性的可追溯材料。机器人技术和人工智慧在导管插入手术中的集成为提高准确性和减少人为错误提供了巨大的成长机会。企业可以透过投资智慧导管技术的研发并扩大其在新兴市场的应用来利用这些机会。然而，挑战包括严格的监管核准和与技术创新相关的高成本，这可能会阻碍市场成长。能够进行复杂的神经血管干预的熟练专业人员数量有限，也可能阻碍其采用。创新可以集中在提高导管灵活性、生物相容性以及开发可以支援各种神经血管手术的多功能导管，从而减少对多种医疗干预的需求。市场相关人员还应专注于加强分销网络，以确保广泛的准入。虽然北美和欧洲目前凭藉先进的医疗基础设施主导了市场，但由于医疗预算不断增加以及神经血管健康公司可以扩大其投资组合的意识不断增强，亚太地区也有可能利润丰厚。总体而言，随着市场的发展，跟上技术进步和以患者为中心的创新对于这一活跃领域的持续业务成长至关重要。

主要市场统计
基准年[2023] 43.7亿美元
预测年份 [2024] 49亿美元
预测年份 [2030] 96.8亿美元
复合年增长率（%） 12.01%

市场动态：快速发展的神经血管导管市场的关键市场洞察

供需的动态交互作用正在改变神经血管导管市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 快速转向微创脑手术
    • 政府支持政策和健康意识提升
    • 神经系统疾病盛行率上升
  • 市场限制因素
    • 导管阻塞的风险
  • 市场机会
    • 神经血管导管技术开发
    • 导管设计的不断进步
  • 市场挑战
    • 神经血管器官生物相容性的限制

波特的五力：驾驭神经血管导管市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解神经血管导管市场的外部影响

外部宏观环境因素在塑造神经血管导管市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解神经血管导管市场的竞争状况

神经血管导管市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵神经血管导管市场供应商绩效评估

FPNV 定位矩阵是评估神经血管导管市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了神经血管导管市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对神经血管导管市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 快速过渡到微创脑外科手术
      • 政府卫生支持政策与提高意识
      • 神经系统疾病盛行率上升
    • 抑制因素
      • 导管阻塞的风险
    • 机会
      • 神经血管导管技术开发
      • 导管设计的不断进步
    • 任务
      • 与神经血管器官的生物相容性的局限性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章神经血管导管市场：依类型

  • 通路导管
  • 球囊导管
  • 栓塞导管
  • 微导管

第七章神经血管导管市场：依应用分类

  • 动静脉畸形
  • 脑动脉瘤
  • 栓塞性中风

第八章神经血管导管市场：依最终用途

  • 门诊手术中心
  • 诊所
  • 诊断中心
  • 医院

第九章美洲神经血管导管市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太神经血管导管市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲神经血管导管市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Acandis GmbH
  • Access Vascular, Inc.
  • Balt USA LLC
  • Biomerics LLC
  • ICU Medical, Inc.
  • Imperative Care Inc.
  • Integra Lifesciences Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic Plc
  • Microvention Inc. by Terumo Corporation
  • Penumbra, Inc.
  • Shape Memory Medical Inc.
  • Spiegelberg Gmbh & Co. KG
  • Stryker Corporation
  • TE Connectivity
  • Teleflex Incorporated
  • Zeus Industrial Products, Inc.
Product Code: MRR-A339DAEF9DC3

The Neurovascular Catheters Market was valued at USD 4.37 billion in 2023, expected to reach USD 4.90 billion in 2024, and is projected to grow at a CAGR of 12.01%, to USD 9.68 billion by 2030.

Neurovascular catheters, integral to the treatment of cerebral vascular disorders, encompass devices used in diagnostic and interventional neurovascular procedures such as embolization, thrombectomy, and angioplasty. The increasing prevalence of neurovascular diseases, technological advancements in minimally invasive surgery, and growing healthcare expenditure drive the demand for these devices, necessitating their development to enhance patient outcomes. Primary applications lie in hospitals and specialized neurology clinics, while end-use dynamics are heavily influenced by the rise in geriatric populations susceptible to neurovascular conditions. Current market growth is buoyed by rapid advancements in catheter technology, including flexible, durable, and trackable materials that improve procedural efficacy and safety. The integration of robotics and AI in catheter procedures presents significant growth opportunities, enhancing precision and reducing human error. Companies can capitalize on these opportunities by investing in R&D for smart catheter technologies and expanding their application in emerging markets. However, challenges include stringent regulatory approvals and high costs associated with innovation, which can impede market growth. Another limitation is the limited number of skilled professionals to perform complex neurovascular interventions, which may hinder widespread adoption. Innovation can be targeted towards enhancing catheter flexibility, biocompatibility, and the development of multifunctional catheters that can assist in various neurovascular procedures, reducing the need for multiple medical interventions. Market players should also focus on strengthening distribution networks to ensure broad accessibility. With North America and Europe currently dominating the market due to advanced healthcare infrastructure, tapping into Asia-Pacific regions presents lucrative potential owing to an increasing healthcare budget and growing awareness of neurovascular health, allowing businesses to expand their portfolio. Overall, as the market evolves, staying attuned to technological advancements and patient-centered innovations will be crucial for sustained business growth in this thriving domain.

KEY MARKET STATISTICS
Base Year [2023] USD 4.37 billion
Estimated Year [2024] USD 4.90 billion
Forecast Year [2030] USD 9.68 billion
CAGR (%) 12.01%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neurovascular Catheters Market

The Neurovascular Catheters Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rapid shift to minimally invasive brain surgeries
    • Supportive government policies concerning health and creating awareness
    • Rising prevalence of neurological conditions
  • Market Restraints
    • Risk of catheter blockage
  • Market Opportunities
    • Technological development in neurovascular catheters
    • Ongoing advances in designs of catheters
  • Market Challenges
    • Limitation in terms of biocompatibility with neurovascular organs

Porter's Five Forces: A Strategic Tool for Navigating the Neurovascular Catheters Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neurovascular Catheters Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neurovascular Catheters Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neurovascular Catheters Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neurovascular Catheters Market

A detailed market share analysis in the Neurovascular Catheters Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neurovascular Catheters Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neurovascular Catheters Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neurovascular Catheters Market

A strategic analysis of the Neurovascular Catheters Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neurovascular Catheters Market, highlighting leading vendors and their innovative profiles. These include Acandis GmbH, Access Vascular, Inc., Balt USA LLC, Biomerics LLC, ICU Medical, Inc., Imperative Care Inc., Integra Lifesciences Corporation, Johnson & Johnson Services, Inc., Medtronic Plc, Microvention Inc. by Terumo Corporation, Penumbra, Inc., Shape Memory Medical Inc., Spiegelberg Gmbh & Co. KG, Stryker Corporation, TE Connectivity, Teleflex Incorporated, and Zeus Industrial Products, Inc..

Market Segmentation & Coverage

This research report categorizes the Neurovascular Catheters Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Access Catheters, Balloon Catheters, Embolization Catheters, and Microcatheters.
  • Based on Application, market is studied across Arteriovenous Malformations, Brain Aneurysm, and Embolic Stroke.
  • Based on End-use, market is studied across Ambulatory Surgical Centers, Clinics, Diagnostic Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rapid shift to minimally invasive brain surgeries
      • 5.1.1.2. Supportive government policies concerning health and creating awareness
      • 5.1.1.3. Rising prevalence of neurological conditions
    • 5.1.2. Restraints
      • 5.1.2.1. Risk of catheter blockage
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological development in neurovascular catheters
      • 5.1.3.2. Ongoing advances in designs of catheters
    • 5.1.4. Challenges
      • 5.1.4.1. Limitation in terms of biocompatibility with neurovascular organs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Neurovascular Catheters Market, by Type

  • 6.1. Introduction
  • 6.2. Access Catheters
  • 6.3. Balloon Catheters
  • 6.4. Embolization Catheters
  • 6.5. Microcatheters

7. Neurovascular Catheters Market, by Application

  • 7.1. Introduction
  • 7.2. Arteriovenous Malformations
  • 7.3. Brain Aneurysm
  • 7.4. Embolic Stroke

8. Neurovascular Catheters Market, by End-use

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Clinics
  • 8.4. Diagnostic Centers
  • 8.5. Hospitals

9. Americas Neurovascular Catheters Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Neurovascular Catheters Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Neurovascular Catheters Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Acandis GmbH
  • 2. Access Vascular, Inc.
  • 3. Balt USA LLC
  • 4. Biomerics LLC
  • 5. ICU Medical, Inc.
  • 6. Imperative Care Inc.
  • 7. Integra Lifesciences Corporation
  • 8. Johnson & Johnson Services, Inc.
  • 9. Medtronic Plc
  • 10. Microvention Inc. by Terumo Corporation
  • 11. Penumbra, Inc.
  • 12. Shape Memory Medical Inc.
  • 13. Spiegelberg Gmbh & Co. KG
  • 14. Stryker Corporation
  • 15. TE Connectivity
  • 16. Teleflex Incorporated
  • 17. Zeus Industrial Products, Inc.

LIST OF FIGURES

  • FIGURE 1. NEUROVASCULAR CATHETERS MARKET RESEARCH PROCESS
  • FIGURE 2. NEUROVASCULAR CATHETERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. NEUROVASCULAR CATHETERS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. NEUROVASCULAR CATHETERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEUROVASCULAR CATHETERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEUROVASCULAR CATHETERS MARKET DYNAMICS
  • TABLE 7. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ACCESS CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY BALLOON CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIC STROKE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 148. NEUROVASCULAR CATHETERS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. NEUROVASCULAR CATHETERS MARKET, FPNV POSITIONING MATRIX, 2023